{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT04240873",
      "OrgStudyIdInfo": {
        "OrgStudyId": "KC19CNSI0469"
      },
      "Organization": {
        "OrgFullName": "Seoul St. Mary's Hospital",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Clinical Study of Intra Articular Injection of Catholic MASTER Cell (Bone Marrow Derived Mesenchymal Stem Cell) in Knee Osteoarthritis",
      "OfficialTitle": "Randomized Double-blind Clinical Study of Intra Articular Injection of Catholic MASTER Cell in Knee Osteoarthritis",
      "Acronym": "MSC-OA"
    },
    "StatusModule": {
      "StatusVerifiedDate": "January 2020",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "November 15, 2019",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "March 31, 2021",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "March 31, 2022",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "December 10, 2019",
      "StudyFirstSubmitQCDate": "January 22, 2020",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "January 27, 2020",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "January 22, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "January 27, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Ji Hyeon Ju",
        "ResponsiblePartyInvestigatorTitle": "Professor",
        "ResponsiblePartyInvestigatorAffiliation": "Seoul St. Mary's Hospital"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Seoul St. Mary's Hospital",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "objective\n\n- safety and efficacy evalaution of MASTER cells injected into knee of patients with osteoarthritis\n\nbackground\n\nosteoarthritis\n\nOsteoarthritis is severe and intractable musculoskeletal disease that eventually leads to joint failure and pain due to inflammation and joint injury.\nOA is one of the most prevalent diseases. The prevalence increases with age, but overuse and trauma can result in OA in young population as well.\nInjured cartilage can not be regenerated spontaneously, untreated injured cartilage eventually leads to osteoarthritis. Surgical treatment may repair the damage but the reparied cartilage may turn out to be fibrocartilage rather than hyaline cartilage.\n\nCurent treatment\n\nmedical therapy: medication for symptom relief, together with exercise. Medications include NSAIDS visco-supplement.\nsurgical therapy: total knee replacement arthroplasty\nto overcome such limitations, cell therapy such as stem cell/ chondrocyte injection is being investigated\n\nHypothesis\n\n- Intra articular injection of MASTER cells will show safety and efficacy in terms of pain and functional improvement.\n\nProtocol 1) deisgn : Injection of MASTER cell 1X 10^8 cells/2cc (experimental arm) or 2cc saline (placebo arm) into knee of patients with osteoarthritis 2) outcomes\n\nprimary outcome : safety evaluation(adverse event)\nsecondary outcomes : check on 1,2,3,6,9,12 months, atient reported outcome (WOMAC, KOOS, IKDC, pain VAS) 3,12 months SF-36, knee MRI score, serum cytokine, bone turnover marker 12 months x-ray 3) Disease\n\nosteoarthritis\n\n4) Subjects\n\ninclusion : age 20-80yrs, diagnosed with OA according to ACR criteria for knee OA, baseline pain VAS equal or more than 50mm\nexclusion: lower extremities surgery within 6months or planned surgery, concommitant systemic rheumatic diseases that can affect the results of the trial, steroid intraarticular inejction into the index knee within 3months, clinicallly meaningful abnormal lab tests (liver function, kidney function)\n\n5) evaluation\n\nprimary outome : compare the number and proportion of of adverse event and lab test abnormalities between the two arms\n\nsecondary outome\n\nchange of 100mm pain VAS\nchange of Western Ontario and McMAster Universities Osteoarthritis (WOMAC) pain VAS, IKDC, KOOS total score\nchange WOMAC sub scale, IKDC, KOOS\nchagne of KHAQ\nchange of MRI indices\nchange of x-ray( joins space narrowing)\nchange of serum ESR/CRP, CTX-II"
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Osteoarthritis, Knee"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "osteoarthritis",
          "mesenchymal stem cell"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Double",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Investigator"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "24",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "MASTER cell",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Intraarticular injection of Catholic MASTER cell, 1 time, 1 x 10^8 cells/DMEM 5cc, into knee joint of patients with osteoarthritis",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Catholic MASTER cell"
              ]
            }
          },
          {
            "ArmGroupLabel": "Saline",
            "ArmGroupType": "Placebo Comparator",
            "ArmGroupDescription": "Intraarticular injection of saline, 1 time, 5cc, into knee joint of patients with osteoarthritis",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Saline"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Catholic MASTER cell",
            "InterventionDescription": "Injection of CATHOLIC MASTER cells 1 x 10^8 cells/DMEM 5cc into knee of patents with osteoarthritis",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "MASTER cell"
              ]
            }
          },
          {
            "InterventionType": "Other",
            "InterventionName": "Saline",
            "InterventionDescription": "Injection of saline 5cc into knee of patents with osteoarthritis",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Saline"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "adverse event according to CTCAE 5.0, clinically meaningful abnormalites in laboratory tests (blood)",
            "PrimaryOutcomeTimeFrame": "Change from Baseline blood abnormalities at 12 month"
          },
          {
            "PrimaryOutcomeMeasure": "Western Ontario and McMaster Universities Arthritis Index (WOMAC) score",
            "PrimaryOutcomeTimeFrame": "Change from Baseline WOMAC score at 12 month"
          },
          {
            "PrimaryOutcomeMeasure": "Knee injury and Osteoarthritis Outcome Score (KOOS)",
            "PrimaryOutcomeTimeFrame": "Change from Baseline KOOS score at 12 month"
          },
          {
            "PrimaryOutcomeMeasure": "International knee documentation committee (IKDC)",
            "PrimaryOutcomeTimeFrame": "Change from Baseline IKDC score at 12 month"
          },
          {
            "PrimaryOutcomeMeasure": "Cartilage damage evaluation through knee MRI",
            "PrimaryOutcomeTimeFrame": "Change from Baseline cartilage morphology at 12 month"
          },
          {
            "PrimaryOutcomeMeasure": "SF-36 questionnaire",
            "PrimaryOutcomeTimeFrame": "Change from Baseline SF-36 score at 12 month"
          },
          {
            "PrimaryOutcomeMeasure": "Serum inflammatory cytokine, acute phase reactant, bone turnover marker",
            "PrimaryOutcomeTimeFrame": "Change from Baseline cytokine level, acute phase reactant, bone turnover marker level at 12 month"
          },
          {
            "PrimaryOutcomeMeasure": "Cartilage damage evaluation through knee x-ray",
            "PrimaryOutcomeTimeFrame": "Change from Baseline cartilage and bone morphology at 12 month"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nAge 20-80\ndiagnosed with knee osteoarthritis (OA) according to ACR classfication criteia for knee OA\nsymptomatic OA that lastede for at least 3 months before screening\nBaseline Pain VAS â‰¥50 mm\ntreated with medication such as acetaminophen, tramadol, NSAID for at least 1month due to OA pain\nX-ray Kellgren-Lawrence grade 1~4\nvolauntarily enrolled with informed consent\nno improvement with medical treatment for at least 3 months\n\nExclusion Criteria:\n\ndisease in spine or lower extremities that can affect the outcome of index knee\nsurgery on lower extremities within 6month before injection or planned\njoint symptoms that can affect the interpretation of the trial data or prevent the subject from enrollement including but not limited to symptomatic fracture, fibromyalgia, rheumatoid arthritis, reactive arthritis\nsteroid injection to the index knee within preivious 3months\nhyaluronic acid injection to the index knee within preivious 6months\nunderwent cell therapy or gene therapy in the past\nmore than 3 times upper normal limit in one or more of the followings: serum creatinine, bilirubin, alanine aminotransferase (ALT) or aspartate aminotransferase (AST) or more than 3 times upper normal limit in two or more of the followings: bilirubin, alanine aminotransferase (ALT) or aspartate aminotransferase (AST)\nparticipation in a different clinical trial other than this within 4 weeks after initiation of the current study\nuse (reccuent use or addiction) of substances that can affect pain sensation such as narcotics\nfemales of childbearing age who do not consent to effective contraceptive methods during the study period\npregnant or lactating woman\nmalignancy\nconsidered to be inappropriate for the trial by investigators",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "20 Years",
      "MaximumAge": "80 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Ji Hyeon Ju, MD, PhD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "82-2-2258-6893",
            "CentralContactEMail": "juji@catholic.ac.kr"
          },
          {
            "CentralContactName": "Jennifer Lee, MD, PhD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "82-2-2258-6893",
            "CentralContactEMail": "poohish@naver.com"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Ji Hyeon Ju, MD, PhD",
            "OverallOfficialAffiliation": "The Catholic University of Korea",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Catholic University of Korea",
            "LocationStatus": "Recruiting",
            "LocationCity": "Seoul",
            "LocationZip": "06950",
            "LocationCountry": "Korea, Republic of",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Ji Hyeon Ju, MD, PhD",
                  "LocationContactRole": "Contact"
                }
              ]
            }
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Undecided"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000010003",
            "ConditionMeshTerm": "Osteoarthritis"
          },
          {
            "ConditionMeshId": "D000020370",
            "ConditionMeshTerm": "Osteoarthritis, Knee"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000001168",
            "ConditionAncestorTerm": "Arthritis"
          },
          {
            "ConditionAncestorId": "D000007592",
            "ConditionAncestorTerm": "Joint Diseases"
          },
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          },
          {
            "ConditionAncestorId": "D000012216",
            "ConditionAncestorTerm": "Rheumatic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M12078",
            "ConditionBrowseLeafName": "Osteoarthritis",
            "ConditionBrowseLeafAsFound": "Osteoarthritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M21321",
            "ConditionBrowseLeafName": "Osteoarthritis, Knee",
            "ConditionBrowseLeafAsFound": "Osteoarthritis, Knee",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3628",
            "ConditionBrowseLeafName": "Arthritis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9773",
            "ConditionBrowseLeafName": "Joint Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14197",
            "ConditionBrowseLeafName": "Rheumatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5475",
            "ConditionBrowseLeafName": "Collagen Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          }
        ]
      }
    }
  }
}